When: 25- 27 November 2020
Where: Online
Start Day 1: 13:00 End Day 3: 16:30 GMT
Course overview
Lectures and workshops will cover the understanding and application of modern approaches and understanding of regulatory requirements for carrying out clinical research, including the latest requirements for IMPD preparation and good distribution practice, ethical and regulatory approval, clinical trials with medical devices and ISO14155, good clinical practice standards, preparation of clinical trial reports, the more demanding requirements of pharmacovigilance and also the legal aspects relevant to clinical trials such as data protection, insurance and codes of practice.
The use of case studies and workshops will assist in the achievement of these learning outcomes and enable the students to contextualise their understanding and knowledge.
Benefits to delegates
- Students will understand the practical aspects of Good Clinical Practice and how it supports clinical research.
- Students will be able to identify the regulatory requirements for clinical research in major markets, understand the importance of the EU Clinical Trial Directive and the requirements and practicalities of preparing the required clinical trial applications and associated documentation.
- Students will gain an insight into the complexities and requirements of pharmacovigilance in clinical research.
- Students will be able to understand the management of clinical trial supplies.
- Students will be able to understand the requirements of Good Manufacturing Practice, authorisation and importation of investigational medicinal products.
- Students will be able to understand clinical trial reporting, the management of the data, data auditing and the practicalities of Good Clinical Practice inspections.
- Students will gain an appreciation of the legal and ethical aspects of clinical research, including insurance, indemnity and the role of the ethics committees and safety boards.
CPD: This course provides 15 CPD hours upon successful completion. To learn more about why Continuing Professional Development is important, visit our Lifelong Learning page.
Programme
The latest course programme will be available closer to the event.
Speakers
TOPRA Masterclasses are developed and delivered by a faculty of expert speakers from relevant industry, agencies, notified bodies and other stakeholders and are validated by the University of Hertfordshire.
|
Graham Bell
Associate Director, Regulatory Strategy & Agency Liaison
PRA Health Sciences |
|
Simon Craige
Consultant Toxicologist
EdGe Toxicology Consulting |
|
Eva Kopecna
Head of Global Regulatory, Pharmacovigilance and Medical Affairs
Acino International |
|
Pierre Omnes
Executive Director, SSU and Regulatory
Syneos Health |
|
Mohamed Oubihi
CEO
Yakumed |
|
Beatrice Panico
Senior Medical Assessor
Medicines and Healthcare products Regulatory Agency (UK) |
|
Angela Stokes
Vice President, Regulatory Affairs Services
Synteract |
|
Sarah Roberts
Vice President and Head of Global Regulatory Affairs
PRA Health Sciences |
|
Emma Whale
Senior GCP and GLP Inspector
Medicines and Healthcare products Regulatory Agency (UK)
|
|
Adela Williams
Partner
Arnold & Porter |
Suitable for
- Students of the MSc programme
- Delegates from the regulatory affairs industry who wish to develop their knowledge of clinical operations
- Delegates from allied industries who wish to have a comprehensive understanding of the subject
Pricing
Course fees:
Type |
Student |
Delegate |
Standard |
£1500+VAT |
£1700+VAT |
Discounted places
A limited number of discounted places are available for those working for regulatory or government agencies, academic institutions, charities, patient groups or full time education at £1275+VAT
Please email us at meetings@topra.org for a discount code before making your booking.
Please note that discounted places are not valid for those enrolled on the MSc course and cannot be used in conjunction with any other offer
|
|
|
|
|
|
|
|
- VAT, if applicable, is charged at 20%
|
|
|
|
|
|
|
|
Related courses:
Module 3: Regulatory Requirements for a New Active Substance: Quality
Module 4: Regulatory Strategy for a New Active Substance: Global Clinical Development
Next steps
Module 6: Regulatory Strategy: From Development to the Market Place
Terms and conditions
By booking a place on this course you are agreeing to the training terms and conditions